Search

Stereotactic radiosurgery (SRS) is increasingly used to treat brain metastases. The technique uses advanced, computer-guided imaging to deliver a highly targeted and intense dose of photon radiation. Since the radiation dose conforms to the three-dimensional shape and size of the target lesion, there is minimal exposure to the rest of the brain and fewer side effects than with standard radiation techniques.

… Monday, March 24, 2025 Stereotactic radiosurgery (SRS) is increasingly used to treat brain metastases. The technique uses advanced, computer-guided imaging to deliver a highly targeted and intense dose of photon radiation. Since the radiation dose conforms to the three-dimensional shape and size of the

Twenty years ago, Charles Sawyers played a pivotal role in the development of Gleevec, a game-changing cancer drug that has gone on to save millions of lives and open doors for research and innovation. In this episode, Dr. Diane Reidy-Lagunes talks with Dr. Sawyers about what’s next in the field of cancer pharmaceuticals. Is another silver bullet on the horizon?

… Friday, December 17, 2021 The outlook used to be bleak for patients diagnosed with chronic myeloid leukemia (CML). But everything changed when the drug Gleevec® (imatinib) was developed 20 years ago and became a “silver bullet,” able to send CML into remission for years. Gleevec has saved millions of

A multi-institutional team led by investigators from Memorial Sloan Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies.

… Friday, October 1, 2010 Discovery Shows that Activating Rearrangements in Receptor Genes are More Common than Previously Thought Media Advisory A multi-institutional team led by investigators from Memorial Sloan Kettering Cancer Center has published a study that provides new insight into genetic changes

Cancer biologist Robert Benezra explains angiogenesis, the process by which new blood vessels form, and how it relates to cancer research.

… Thursday, March 13, 2014 Summary Cancer biologist Robert Benezra explains angiogenesis, the process by which new blood vessels form, and how it relates to cancer research. Angiogenesis is the process by which new blood vessels form, allowing the delivery of oxygen and nutrients to the body’s tissues.

New MSK research finds both acupuncture and massage can benefit those with cancer-related pain; investigates relapse after CAR T cell therapy for multiple-myeloma; and showcases the power of open-source science to develop medicines against COVID-19 and other pandemics.

… Monday, November 27, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) finds both acupuncture and massage can benefit those with cancer-related pain; investigates relapse after CAR T cell therapy for multiple-myeloma; and showcases the power of open-source science to develop medicines

Researchers have identified a specific group of microRNA molecules that are responsible for controlling genes that cause breast cancer metastasis.

… Wednesday, January 9, 2008 Researchers have identified a specific group of microRNA molecules that are responsible for controlling genes that cause breast cancer metastasis. The study, led by scientists at Memorial Sloan Kettering Cancer Center (MSKCC), appears in the January 10, 2008, issue of Nature

SKI researchers have learned how tiny droplets prevent a cancer-causing type of messenger RNA from being degraded in leukemia cells.

… Thursday, May 27, 2021 Cancer cells have many ways to protect themselves from the body’s natural defense systems. Recently, researchers in the Sloan Kettering Institute discovered a new one: Some cancer cells are able to form protective droplets called nuclear bodies around the genetic material that

MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations.

… Wednesday, January 5, 2022 The underlying genetic causes of cancer have traditionally been put into one of two categories: Tumors are caused either by somatic mutations, which arise by chance over the course of a person’s life, or by germline mutations, which are inherited at birth from a parent and

Learn more from Andrea Cercek about a new study showing that colorectal cancer rates are increasing in younger people.

… Tuesday, February 28, 2017 Summary MSK expert Andrea Cercek discusses findings from a new study showing rising colorectal cancer rates among people in their 20s and 30s. Though the overall incidence of colorectal cancer has been on the decline in the US for years, it is increasing among individuals in

Read about a new CAR T cell therapy now approved for marginal zone lymphoma (MZL).

… Friday, December 12, 2025 Marginal zone lymphoma is a slow-growing, rare form of  non-Hodgkin lymphoma that usually responds well to initial therapies. But in some patients, the disease keeps returning despite multiple treatments. Now the U.S. Food and Drug Administration (FDA) has approved a new therapy